James Hurley

Lead PI (Core Leadership)

Team Hurley

PD Functional Genomics

James Hurley, PhD, is a professor of molecular and cell biology at the University of California at Berkeley. He is a member of the US National Academy of Sciences and the American Academy of Arts and Sciences. He obtained his PhD in biophysics at UCSF and was a postdoctoral fellow at the University of Oregon. He was led a group in the NIH intramural program from 1992 to 2013, before moving to UC Berkeley. He is leading structural biologist in the fields of autophagy and the endolysosomal system. He has made many contributions to understanding the molecular gymnastics of the mitophagy core complexes during mitophagy initiation and phagophore expansion using crystallography, single particle EM, cryo-EM, prediction tools and reconstitutions of autophagy. His newest interest and a major focus in the lab is converting insights from structural biology and biochemistry of the autophagic and endolysosomal pathways into therapies for neurodegenerative diseases.

University of California, Berkeley | United States
Lead PI (Core Leadership)

James Hurley

University of California, Berkeley

James Hurley, PhD, is a professor of molecular and cell biology at the University of California at Berkeley. He is a member of the US National Academy of Sciences and the American Academy of Arts and Sciences. He obtained his PhD in biophysics at UCSF and was a postdoctoral fellow at the University of Oregon. He was led a group in the NIH intramural program from 1992 to 2013, before moving to UC Berkeley. He is leading structural biologist in the fields of autophagy and the endolysosomal system. He has made many contributions to understanding the molecular gymnastics of the mitophagy core complexes during mitophagy initiation and phagophore expansion using crystallography, single particle EM, cryo-EM, prediction tools and reconstitutions of autophagy. His newest interest and a major focus in the lab is converting insights from structural biology and biochemistry of the autophagic and endolysosomal pathways into therapies for neurodegenerative diseases.

Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.